Related Experiment Video
Updated: Mar 28, 2026

Author Spotlight: Noninvasive Cerebral Blood Flow Determination in Human Functional Brain Region for Diagnosis of Neurological Disorders
Published on: May 31, 2024
A novel approach to measure local cerebral haematocrit using MRI
Fernando Calamante1, André Ahlgren2, Matthias J P van Osch3
1The Florey Institute of Neuroscience and Mental Health, Melbourne, Australia The Florey Department of Neuroscience and Mental Health, University of Melbourne, Melbourne, Australia Department of Medicine, Austin Health and Northern Health, University of Melbourne, Australia fernando.calamante@florey.edu.au.
Abstract:
The percentage blood volume occupied by red blood cells is known as haematocrit. While it is straightforward to measure haematocrit in large arteries, it is very challenging to do it in microvasculature (cerebral haematocrit). Currently, this can only be done using invasive methods (e.g. PET), but their use is very limited. Local variations in cerebral haematocrit have been reported in various brain abnormalities (e.g. stroke, tumours). We propose a new approach to image cerebral haematocrit using MRI, which relies on combining data from two measurements: one that provideshaematocrit-weightedand other onehaematocrit-independentvalues of the same parameter, thus providing an easily obtainable measurement of this important physiological parameter. Four different implementations are described, with one illustrated as proof-of-concept using data from healthy subjects. Cerebral haematocrit measurements were found to be in general agreement with literature values from invasive techniques (e.g. cerebral/arterial ratios of 0.88 and 0.86 for sub-cortical and cortical regions), and showed good test-retest reproducibility (e.g. coefficient-of-variation: 15% and 13% for those regions). The method was also able to detect statistically significant haematocrit gender differences in cortical regions (p < 0.01). The proposed MRI technique should have important applications in various neurological diseases, such as in stroke and brain tumours.

